Lumibird Medical has launched its new Capsulo Nd:YAG laser platform, designed for efficient and accurate capsulotomy and iridotomy treatments.
On Tuesday 19 April, the parent company of ophthalmic laser manufacturers Quantel Medical (France and Poland) and Ellex (Australia, Japan and US) unveiled the next generation laser system that it described as easy-to-use and versatile.
In a statement, it said in the literature the incidence of post-operative secondary cataract varies anywhere between 10-50% within three to five years, demonstrating the need for dedicated treatments.
“With the redesign of Quantel Medical’s flagship Nd:YAG Laser, Lumibird Medical delivers Capsulo; the next generation technology, continuing to support this important growing market need,” Lumibird stated.
Mr Matthew Metcalfe, anterior segment laser product manager at Lumibird Medical, said Capsulo is built with exclusive high-quality optics delivering pristine clarity of view into the anterior and posterior segments of the eye.
“Advanced illumination with a variable-height light tower offers dual illumination angles of 16 and 7.5° for anterior and posterior laser applications,” he said.
The Capsulo Nd:YAG laser can be paired with the Quantel Medical Vitra 2 MultiSpot photocoagulating laser, also from Lumibird Medical, combining pan-retinal photocoagulation functionality through a single slit lamp.
Mr Jean-Marc Gendre, CEO of Lumibird Medical added: “Capsulo, when combined with the Vitra 2 photocoagulator, offers an ideal all-in one laser platform, and we are extremely proud to provide this highly versatile solution into the hands of discerning ophthalmologists.”
Delegates attending The French Society of Ophthalmology (SFO) Congress in Paris, 7-9 May 2022, will have the opportunity to see the Capsulo laser on the Lumibird Medical booth #F9. CE Marked and FDA pending, Capsulo laser is now available in the EU.